Market Access

Lead Indication Strategy

In which indication can we secure the highest price and the most stable reimbursement path?

HTA Resistance Mapping

Identify therapeutic areas with the lowest historical "No Added Benefit" rates in Germany (G-BA) and France (HAS).

Pricing Ceiling Analysis

Compare "Price Anchors" (cost of current Standard of Care) across indications to find the highest entry point.

Indication Sequencing

Simulate how the first indication's price will set the "Price Anchor" for all future label expansions.

Pricing Corridor & Scenario Modeling

What is the realistic pricing corridor, and how do clinical outcomes dictate the negotiation floor?

Outcome-Price Correlation

Model the expected price corridor for each HTA rating (e.g., the exact price delta between "Minor" vs. "Considerable" added benefit).

Analog Benchmarking

AI-driven analysis of realized net prices for similar products, adjusted for therapeutic value and market entry date.

The "Safe Zone"

Define the negotiation floor and ceiling by calculating historical acceptance ranges for comparable clinical profiles.

Evidence Maturity & Launch Timing

Is our data mature enough to launch, or are we walking into a "No Added Benefit" trap?

Interim-Read-out Simulation

Predict if a "fast" submission based on interim data provides enough statistical power for G-BA/HAS acceptance.

Data Maturity Radar

Compare your trial's current data maturity (e.g., % of OS events) against historical thresholds required for positive assessments.

HTA Outcome Prediction (The Core Engine)

What is the statistical probability of achieving a specific "Added Benefit" (DE) or "ASMR" (FR) rating?

Predictive Rating

Probabilistic forecasting of benefit categories based on your current efficacy and safety profile.

Driver Analysis

Pinpoint exactly which data points (e.g., HR for Morbidity vs. Quality of Life) will drive the final decision.

Sensitivity Modeling

Simulate how shifts in clinical outcomes (e.g., a wider confidence interval) impact the final price negotiation corridor.

Negotiation Strategy & Objection Radar

Which "Red Flags" will authorities raise, and how can we preemptively neutralize them?

Objection Forecasting

AI-driven identification of the top 5 criticisms payers will raise (e.g., regarding ACT choice or subgroup definitions).

Rescue Strategy Mapping

Use historical precedents to find successful counter-arguments or post-hoc analyses that have salvaged past negotiations.

Secondary Endpoint Optimization

Identify "hidden value" in morbidity or QoL data that can compensate for a non-superior primary endpoint.

From Guesswork to Predictive Precision:
Optimize Your Asset ROI.

The Strategic Questions We Answer

Lead Indication Strategy

Pricing Corridor & Scenario Modeling

Evidence Maturity & Launch Timing

HTA Outcome Prediction (The Core Engine)

Negotiation Strategy & Objection Radar

The "Risk Radar" Advantage

High Acceptance Rates

Optimized Pricing

Faster Approval

Ready to predict your HTA outcome?

From Guesswork to Predictive Precision: Optimize Your Asset ROI.

The Strategic Questions We Answer

Lead Indication Strategy

Pricing Corridor & Scenario Modeling

Evidence Maturity & Launch Timing

HTA Outcome Prediction (The Core Engine)

Negotiation Strategy & Objection Radar

The "Risk Radar" Advantage

High Acceptance Rates

Optimized Pricing

Faster Approval

Ready to predict your HTA outcome?

From Guesswork to Predictive Precision:
Optimize Your Asset ROI.